These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 21854453)

  • 1. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
    Levinsen M; Shabaneh D; Bohnstedt C; Harila-Saari A; Jonsson OG; Kanerva J; Lindblom A; Lund B; Andersen EW; Schmiegelow K;
    Eur J Haematol; 2012 Jan; 88(1):78-86. PubMed ID: 21854453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia.
    Poulsen A; Demeny AK; Bang Plum C; Gjerum Nielsen K; Schmiegelow K
    Med Pediatr Oncol; 2001 Jul; 37(1):20-3. PubMed ID: 11466718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia.
    Agrawal AK; Chang PP; Feusner J
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e1-4. PubMed ID: 21102354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    Nazir HF; Elshinawy M; AlRawas A; Khater D; Zadjaly S; Wali Y
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):203-208. PubMed ID: 28234744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG; Nageswaran S; Valentine ME; McKinney RE
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia.
    Weinthal J; Frost JD; Briones G; Cairo MS
    J Clin Oncol; 1994 Jan; 12(1):136-40. PubMed ID: 8270969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circadian schedule for childhood acute lymphoblastic leukemia maintenance therapy does not influence event-free survival in the NOPHO ALL92 protocol.
    Clemmensen KK; Christensen RH; Shabaneh DN; Harila-Saari A; Heyman M; Jonsson OG; Wesenberg F; Rosthøj S; Schmiegelow K;
    Pediatr Blood Cancer; 2014 Apr; 61(4):653-8. PubMed ID: 24265159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
    J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis carinii pneumonia prophylaxis and early clinical manifestations of severe perinatal human immunodeficiency virus type 1 infection. Northern California Pediatric HIV Consortium.
    Maldonado YA; Araneta RG; Hersh AL
    Pediatr Infect Dis J; 1998 May; 17(5):398-402. PubMed ID: 9613653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate.
    Watts CS; Sciasci JN; Pauley JL; Panetta JC; Pei D; Cheng C; Christensen CM; Mikkelsen TS; Pui CH; Jeha S; Relling MV
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):449-52. PubMed ID: 27322715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
    BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis.
    Rungoe C; Malchau EL; Larsen LN; Schroeder H
    Pediatr Blood Cancer; 2010 Aug; 55(2):304-8. PubMed ID: 20583218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases.
    Takenaka K; Komiya Y; Ota M; Yamazaki H; Nagasaka K
    Mod Rheumatol; 2013 Jul; 23(4):752-8. PubMed ID: 22907597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia].
    Enomoto T; Azuma A; Matsumoto A; Nei T; Hiramatsu K; Abe S; Usuki J; Kudoh S
    Nihon Kokyuki Gakkai Zasshi; 2005 Dec; 43(12):725-30. PubMed ID: 16457333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
    Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
    Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.
    Para MF; Finkelstein D; Becker S; Dohn M; Walawander A; Black JR
    J Acquir Immune Defic Syndr; 2000 Aug; 24(4):337-43. PubMed ID: 11015150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
    Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.